ATXS logo

Astria Therapeutics (ATXS) Company Overview

Profile

Full Name:

Astria Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 25, 2015

Indexes:

Not included

Description:

Astria Therapeutics (ATXS) focuses on developing innovative treatments for rare diseases, particularly those related to genetic disorders. The company aims to improve patients' lives through advanced therapies and research, targeting conditions that currently have limited or no effective treatments available.

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 20, 2021

Analyst ratings

Recent major analysts updates

Mar 3, 25 Citizens Capital Markets
Market Outperform
Feb 27, 25 HC Wainwright & Co.
Buy
Jan 31, 25 JMP Securities
Market Outperform
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Oppenheimer
Outperform
Nov 14, 24 HC Wainwright & Co.
Buy
Sep 27, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Astria Therapeutics?
  • Does Astria Therapeutics pay dividends?
  • What sector is Astria Therapeutics in?
  • What industry is Astria Therapeutics in?
  • What country is Astria Therapeutics based in?
  • When did Astria Therapeutics go public?
  • Is Astria Therapeutics in the S&P 500?
  • Is Astria Therapeutics in the NASDAQ 100?
  • Is Astria Therapeutics in the Dow Jones?
  • When was Astria Therapeutics's last earnings report?
  • When does Astria Therapeutics report earnings?
  • Should I buy Astria Therapeutics stock now?

What is the ticker symbol for Astria Therapeutics?

The ticker symbol for Astria Therapeutics is NASDAQ:ATXS

Does Astria Therapeutics pay dividends?

No, Astria Therapeutics does not pay dividends

What sector is Astria Therapeutics in?

Astria Therapeutics is in the Healthcare sector

What industry is Astria Therapeutics in?

Astria Therapeutics is in the Biotechnology industry

What country is Astria Therapeutics based in?

Astria Therapeutics is headquartered in United States

When did Astria Therapeutics go public?

Astria Therapeutics's initial public offering (IPO) was on June 25, 2015

Is Astria Therapeutics in the S&P 500?

No, Astria Therapeutics is not included in the S&P 500 index

Is Astria Therapeutics in the NASDAQ 100?

No, Astria Therapeutics is not included in the NASDAQ 100 index

Is Astria Therapeutics in the Dow Jones?

No, Astria Therapeutics is not included in the Dow Jones index

When was Astria Therapeutics's last earnings report?

Astria Therapeutics's most recent earnings report was on Nov 13, 2024

When does Astria Therapeutics report earnings?

The next expected earnings date for Astria Therapeutics is Mar 11, 2025

Should I buy Astria Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions